BERKELEY, Calif., March 20, 2017 /PRNewswire/ -- Dr. Reggie Gaudino, VP, Science and Intellectual Property for Steep Hill, the global leader in cannabis science, testing and analytics, will highlight the applications and benefits of DNA-based testing of cannabis at this year's CannaTech, taking place in Tel Aviv, Israel, on March 20 – 22, 2017. Dr. Gaudino is available for scheduled media interviews to discuss Steep Hill's pioneering cannabis DNA-based marker-assisted breeding program and additional Steep Hill scientific advancements related to cannabis DNA, IP, safety and health.
Steep Hill's core business is centered on testing and analyzing cannabis to ensure compliance with public safety standards, while also serving as one of the first companies to apply next-generation genetics-based technologies and techniques to breeding cannabis. Steep Hill helps breeders focus resources and create specific strains, using DNA-based marker-assisted breeding, leveraging the best of what has been developed for other commercial agricultural products. This advanced methodology is far more cost-effective for growers, producing greater yield per-area, and per-time unit.
Dr. Gaudino believes these innovative techniques will create better formulations, thereby requiring lower dosing alongside the ability to blend a personalized formulation for an increased number of applications for patient and consumer use. He predicts future benefits will include the power to breed specific strains based on genetic profiles that can be used for specific patient conditions and diseases.
"Due to the country's long-established ecosystem in this field, Israel is on the cutting-edge of patient-focused research," says Dr. Gaudino. "I am excited to participate in CannaTech 2017, as it allows us to share our genetic research and marker-assisted breeding development program with the industry's top innovators and work collaboratively to further advance the industry, on both scientific and patient application fronts."
Leading researchers, scientists, hi-tech, ag-tech and pharma experts from Israel and around the world are gathering at CannaTech 2017 to accelerate cannabis innovation, in an event led by iCan: Israel Cannabis.
Full event details visit: www.canna-tech.co
For more information about Steep Hill visit: www.steephill.com
ABOUT STEEP HILL
Steep Hill Labs, Inc. is the largest cannabis lab network in the world. Founded in the United States in 2008, Steep Hill is a science and technology firm that has become recognized as the global industry leader in cannabis testing and analytics. The company pioneered the first medical cannabis potency testing methodology for use in California—the first U.S. state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann™, QuantaCann2™, GenKit™, Steep Hill Express™ and tests for microbiological contaminants, genetic markers and DNA identification. Steep Hill is expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt "best practices" in cannabis testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world.
ABOUT CANNATECH 2017
CannaTech is an annual event hosted in Israel, a country known as a heartland of innovation. CannaTech is designed to bring together the world's most dynamic cannabis professionals for the opportunity to network, kick around conventional thinking about medical cannabis, become connected, and leave inspired.
CannaTech showcases the full spectrum of global industry leaders, spanning the fields of science, research, finance, medicine, government policy, tech innovation, agriculture and entrepreneurship, at one outstanding event with a singular focus on the cannabis industry and all of the opportunity that surrounds it.
Contact: Cathie Bennett Warner | Cell: +1-415-420-1573 | 151186@email4pr.com
SOURCE Steep Hill